1. Canada Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Captor Capital Corp

Captor Capital Corp

CCSE:CPTR
0.33
CAD
+0.02
(+6.45%)
-1.62EPS
767,125.04Market Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
-2.27
-3.08
-1.91
19.7
- -
2.33
4.82
6.3
9.49
12.05
10.59
- -
- -
- -
Basic EPS, GAAP
-7.09
-7
-4.85
18.87
4.94
-18.44
-12.67
-2.28
-4.19
-3.74
-3.28
2.21
-1.83
-1.62
Free Cash Flow per Basic Share
-4.41
-1.93
-0.53
-1
-3.05
-3.3
-4.69
-1.72
-2.27
-0.37
-0.19
-2.06
-0.96
-0.97
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
7.09
0.09
-4.76
14.11
35.13
26.24
13.56
10.46
8.02
4.81
1.6
4.24
2.41
2.37
Tangible Book Value per Share
7.09
0.09
-4.76
14.11
35.13
21.24
8.26
1.24
3.01
0.89
0.04
4.24
2.41
2.37
Basic Weighted Avg Shares
- -
- -
- -
- -
1
3
3
3
3
3
3
3
3
3
Sales/Revenue/Turnover
-1
-1
-1
9
- -
6
12
16
33
42
37
- -
- -
- -
Operating Margin (%)
264.04
142.44
186.22
-8.24
- -
-287.55
-61.63
-37.61
-19.1
-4.45
-0.47
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
1
2
3
3
3
- -
- -
- -
Net Income, GAAP
-3
-3
-2
8
4
-46
-33
-6
-14
-13
-11
8
-6
-6
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
312.4
227.43
253.97
95.79
- -
-791.66
-263.11
-36.18
-44.14
-31.03
-30.96
- -
- -
- -
Working Capital
2
-1
-3
- -
71
57
21
13
17
8
1
15
8
8
LT Debt
- -
- -
- -
- -
- -
- -
1
9
7
6
5
- -
- -
- -
Total Equity
3
- -
-2
6
71
69
35
39
36
21
5
15
8
8
Return on Invested Capital (%)
- -
- -
- -
-19.19
-3.65
- -
- -
- -
- -
- -
- -
49.06
- -
- -
Return on Capital (%)
- -
- -
- -
363.08
9.84
- -
- -
- -
- -
- -
- -
57.92
- -
- -
Return on Common Equity (%)
-66.66
-195.15
- -
- -
9.84
-66.38
-63.06
-18.97
-52.81
-58.24
-102.1
75.67
-54.98
-50.84

Capital Structure

CAD

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
3
Market Capitalization
1
1
1

Working Capital

CAD

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
15
10
10
Cash, Cash Equivalents & STI
13
8
8
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
- -
1
1
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
62.38%
4.35%
-43.13%
Free Cash Flow
161.02%
170.74%
-53.24%
Net Income, GAAP
-220.96%
-45.33%
-182.79%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
8.72
-0.34
0.5
-6.63
2.21
2026
-0.25
-0.03
-0.01
-1.54
-1.83
2027
-0.04
- -
- -
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
John Zorbas
Full Time Employees
78
Sector
Health technology
Industry
Pharmaceuticals: other
Address
4 King Street West Toronto ON Canada M5H 1B6
IPO Date
Oct 30, 2017
Website
captorcapital.com
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
Captor Capital Corp. Captor Capital Corp. is a Canada-based investment company focused on the cannabis sector and merchant banking activities; it engages in the retail sale, marketing, and supply of recreational and medical cannabis products, cannabis-based goods, and related strains through its proprietary One Plant retail dispensaries and online delivery networks located in Santa Cruz, Antioch, Salinas, Lompoc, Goleta, Atwater, and Castroville in California, United States. Founded in 2003 and headquartered in Toronto, Ontario, the company operates as a vertically integrated cannabis entity with reportable segments in Canada, the United States, and other regions, providing capital for medical and recreational cannabis cultivation and distribution solutions while pursuing long-term shareholder growth through diversified investments. Recent strategic developments include a US$500,000 Bitcoin acquisition for treasury holdings in May 2025 to support growth initiatives and the issuance of a US$450,000 convertible loan note from a European institutional investor, alongside historical shifts such as its name change from NWT Uranium Corp. in June 2017 and prior expansions like the announced acquisition of I-5 Holdings Ltd. with up to $20 million private placement financing.